We ship !

We are not shipping goods to USA
except BioBeam 940

Clinical Studies

Double blind tests have documented that BioBeam 940 treatment significantly lessens pain associated with chronic tendonitis and facet joint arthritis. Patients with degenerative knee diseases and chondromalacia patella showed a significant improvement in pain, power, ability to negotiate stairs, and walking tolerance.

The BioBeam 940 light source has special healing properties which are not found in nature. The device uses narrow band non-visible infrared light to relieve symptomatic joint pain in rheumatic or arthritic conditions such as back pain and knee pain.

This light source possesses special qualities accelerating the natural healing process, resulting in fewer medical treatments and medication.

The BioBeam 940 treatment is intended to be used in conjunction with prescribed treatment of a licensed medical practitioner, and is not intended to replace such treatments, unless specifically recommended by a physician.


In all cases, it is strongly recommended to consult with a physician before use.

 

Improvements of Pain and Disability

Improvements of Pain and Disability in Elderly Patients with Degenerative Osteoarthritis of the knee Treated with Narrow- Band Light Therapy
Jean Stelian, MD, Israel Gil, MD, Beni Habot, MD, Michal Rosenthal, MD, Iulian Abramovich, MD, Nathalia Kutok, MD, and Auni Khahil, MD  


Objective: To evaluate the effects of low-power light therapy on pain and disability in elderly patients with degenerative osteoarthritis of the knee.
Design: partially double-blinded, fully randomized trial comparing Red, infrared, and placebo light emitters.
Patients: fifty patients with degenerative osteoarthritis of both knees were randomly assigned to three treatment groups: red (15 patients), Infrared (18 patients), and placebo (17 patients). Infrared and placebo emitters were double blinded.
Interventions: self-applied treatment to both sides of the knee for 15 minutes. Twice a day for 10 days.
Main outcome measures: Short-Form McGill Pain Questionnaire, Present Pain intensity, Visual Analogue Scale for pain, and Disability Index Questionnaire for disability were used. We evaluated pain and disability before and on the tenth day of therapy. The period from the end of the treatment until the patient`s request for treatment to be restarted was summed up 1 year after the trial.
Results: Pain and disability before treatment did not show statistically significant differences between the three groups. Pai reduction in the red and infrared groups after the treatment was more than 50% in all scoring methods (P<0.05). There was no significant pain improvement in the placebo group. We observed significant functional improvement in red and infrared treated groups (p<0.05), but not in the placebo group. The period from the end of the treatment until the patient required retreatment was longer for red and infrared groups than for the placebo group (4.2±3.0,6.1±3.2, and 0.53±0.62 months, for red, infrared, and placebo, respectively).
Conclusions: Low-power light therapy is effective in relieving pain and disability in degenerative Osteoarthritis of the knee.
Reference: Jags January 1992, vol. 40 No. 1

 

Ease of Pain and Disability

easeofpainEase of Pain and Disability in Elderly Patients with Degenerative Osteoarthritis of the knee treated by Narrow-Band Light Therapy (BioBeam).          
Tel-Aviv University, Sackler Faculty of Medicine Department of Physical Therapy.
By Jean Stilian MD, E.Cohen, RPT, M. Finkelstien RPT

read more...

 

Low Energy Narrow Band

Low Energy Narrow Band Non-Coherent Infrared Illumination of human semen and isolated sperm (A study of BioBeam Devices)

R. Singer, M. Saiv, M. Barnet, H. Levinsky, E. segenreich, Y. Fuchs, E. Mendes and H. Yehoshua.

Summary:
Sixty-two samples of human normal and abnormal semen and 23 samples of washed sperm were illuminated for 4 minutes with a narrow band non-coherent infrared device (BioBeam). Immediately after illumination, the following parameters were examined in comparison with appropriate controls: motility, viability and morphology, fructose content of semen, across some reaction of sperm, viscosity of seminal plasma and analysis of the protein pattern. The mean value of motility grade calculated for the total number of 62 semen samples was 2.58±0.79 versus 2.17±0.75 (non illuminated controls), P<0.05.

read more...

Clinical Studies

Double blind tests have documented that BioBeam 940 treatment significantly lessens pain associated with chronic tendonitis and facet joint arthritis. Patients with degenerative knee diseases and chondromalacia patella showed a significant improvement in pain, power, ability to negotiate stairs, and walking tolerance.

The BioBeam 940 light source has special healing properties which are not found in nature. The device uses narrow band non-visible infrared light to relieve symptomatic joint pain in rheumatic or arthritic conditions such as back pain and knee pain.

This light source possesses special qualities accelerating the natural healing process, resulting in fewer medical treatments and medication.

The BioBeam 940 treatment is intended to be used in conjunction with prescribed treatment of a licensed medical practitioner, and is not intended to replace such treatments, unless specifically recommended by a physician.


In all cases, it is strongly recommended to consult with a physician before use.

 

Improvements of Pain and Disability

Improvements of Pain and Disability in Elderly Patients with Degenerative Osteoarthritis of the knee Treated with Narrow- Band Light Therapy
Jean Stelian, MD, Israel Gil, MD, Beni Habot, MD, Michal Rosenthal, MD, Iulian Abramovich, MD, Nathalia Kutok, MD, and Auni Khahil, MD  


Objective: To evaluate the effects of low-power light therapy on pain and disability in elderly patients with degenerative osteoarthritis of the knee.
Design: partially double-blinded, fully randomized trial comparing Red, infrared, and placebo light emitters.
Patients: fifty patients with degenerative osteoarthritis of both knees were randomly assigned to three treatment groups: red (15 patients), Infrared (18 patients), and placebo (17 patients). Infrared and placebo emitters were double blinded.
Interventions: self-applied treatment to both sides of the knee for 15 minutes. Twice a day for 10 days.
Main outcome measures: Short-Form McGill Pain Questionnaire, Present Pain intensity, Visual Analogue Scale for pain, and Disability Index Questionnaire for disability were used. We evaluated pain and disability before and on the tenth day of therapy. The period from the end of the treatment until the patient`s request for treatment to be restarted was summed up 1 year after the trial.
Results: Pain and disability before treatment did not show statistically significant differences between the three groups. Pai reduction in the red and infrared groups after the treatment was more than 50% in all scoring methods (P<0.05). There was no significant pain improvement in the placebo group. We observed significant functional improvement in red and infrared treated groups (p<0.05), but not in the placebo group. The period from the end of the treatment until the patient required retreatment was longer for red and infrared groups than for the placebo group (4.2±3.0,6.1±3.2, and 0.53±0.62 months, for red, infrared, and placebo, respectively).
Conclusions: Low-power light therapy is effective in relieving pain and disability in degenerative Osteoarthritis of the knee.
Reference: Jags January 1992, vol. 40 No. 1

 

Ease of Pain and Disability

easeofpainEase of Pain and Disability in Elderly Patients with Degenerative Osteoarthritis of the knee treated by Narrow-Band Light Therapy (BioBeam).          
Tel-Aviv University, Sackler Faculty of Medicine Department of Physical Therapy.
By Jean Stilian MD, E.Cohen, RPT, M. Finkelstien RPT

read more...

 

Low Energy Narrow Band

Low Energy Narrow Band Non-Coherent Infrared Illumination of human semen and isolated sperm (A study of BioBeam Devices)

R. Singer, M. Saiv, M. Barnet, H. Levinsky, E. segenreich, Y. Fuchs, E. Mendes and H. Yehoshua.

Summary:
Sixty-two samples of human normal and abnormal semen and 23 samples of washed sperm were illuminated for 4 minutes with a narrow band non-coherent infrared device (BioBeam). Immediately after illumination, the following parameters were examined in comparison with appropriate controls: motility, viability and morphology, fructose content of semen, across some reaction of sperm, viscosity of seminal plasma and analysis of the protein pattern. The mean value of motility grade calculated for the total number of 62 semen samples was 2.58±0.79 versus 2.17±0.75 (non illuminated controls), P<0.05.

read more...

 

 

$179.95

 

 

 

$179.95